Chemotherapy and targeted therapies have significantly improved the prognosis of
oncology patients. However, these antineoplastic treatments may also induce adverse …

Abstract The Hatter Cardiovascular Institute biennial workshop, originally scheduled for April
2020 but postponed for 2 years due to the Covid pandemic, was organised to debate and …

Background Doxorubicin (DOX) is among the most widely employed antitumor agents,
although its clinical applications have been largely hindered by severe cardiotoxicity. Earlier …

Skin flaps are necessary in plastic and reconstructive surgery for the removal of skin cancer,
wounds, and ulcers. A skin flap is a portion of skin with its own blood supply that is partially …

Background: Dietary polyphenols help to prevent cardiovascular diseases, and interactions
between polyphenols and gut microbiota are known to exist. In this study, we speculated that …

Cardiovascular disease is the major cause of morbidity and mortality in breast cancer
survivors. Chemotherapy contributes to this risk. We aimed to define the mechanisms of long …

Despite improvements in cancer survival, cancer therapy–related cardiovascular toxicity has
risen to become a prominent clinical challenge. This has led to the growth of the burgeoning …

Abstract Purpose of Review Cardiovascular disease is long-term complication of both
cancer and anti-cancer treatment and can have significant ramifications for health-related …

Doxorubicin (DOX) has been recognized as one of the most effective chemotherapies and
extensively used in the clinical settings of human cancer. However, DOX-mediated …

We review some of the important discoveries and advances made in basic and translational
cardiac research in 2020. For example, in the field of myocardial infarction (MI), new aspects …